• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

预测急性缺血性脑卒中患者发病至治疗时间对90天时改良Rankin量表评分的影响。

Prediction modelling the impact of onset to treatment time on the modified Rankin Scale score at 90 days for patients with acute ischaemic stroke.

作者信息

Ennab Vogel Nicklas, Tatlisumak Turgut, Wester Per, Lyth Johan, Levin Lars-Åke

机构信息

Department of Health, Medicine and Caring Sciences, Faculty of Medicine and Health Sciences, Linköping University, Linköping, Sweden.

Neurology, Sahlgrenska University Hospital, Göteborg, Sweden.

出版信息

BMJ Neurol Open. 2022 Aug 16;4(2):e000312. doi: 10.1136/bmjno-2022-000312. eCollection 2022.

DOI:10.1136/bmjno-2022-000312
PMID:36072349
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9386213/
Abstract

INTRODUCTION

Shortening the time from stroke onset to treatment increases the effectiveness of endovascular stroke therapies.

AIM

This study aimed to predict the modified Rankin Scale score at 90 days post-stroke (mRS-90d score) in patients with acute ischaemic stroke (AIS) with respect to four types of treatment: conservative therapy (CVT), intravenous thrombolysis only (IVT), mechanical thrombectomy only (MT) and pretreatment with IVT before MT (IVT+MT).

PATIENTS AND METHODS

This nationwide observational study included 124 484 confirmed cases of acute stroke in Sweden over 6 years (2012-2017). The associations between onset-to-treatment time (OTT), patient age and hospital admission National Institutes of Health Stroke Scale (NIHSS) score with the five-levelled mRS-90d score were retrospectively studied. A generalised linear model (GLM) was fitted to predict the mRS-90d scores for each patient group.

RESULTS

The fitted GLM for CVT patients is a function of age and NIHSS score. For IVT, MT and IVT+MT patients, GLMs additionally employed OTT variables. By reducing the mean OTTs by 15 min, the number needed-to-treat (NNT) for one patient to make a favourable one-step shift in the mRS was 30 for IVT, 48 for MT and 21 for IVT+MT.

DISCUSSION AND CONCLUSION

This study demonstrates linear associations of mRS-90d score with OTT for IVT, MT and IVT+MT, and shows in absolute effects measures that OTT reductions for IVT and/or MT produces substantial health gains for patients with AIS. Even moderate OTT reductions led to sharp drops in the NNT.

摘要

引言

缩短中风发作至治疗的时间可提高血管内中风治疗的效果。

目的

本研究旨在预测急性缺血性中风(AIS)患者在中风后90天的改良Rankin量表评分(mRS-90d评分),涉及四种治疗类型:保守治疗(CVT)、仅静脉溶栓(IVT)、仅机械取栓(MT)以及在MT前进行IVT预处理(IVT+MT)。

患者与方法

这项全国性观察性研究纳入了瑞典6年(2012 - 2017年)期间124484例确诊的急性中风病例。回顾性研究了发作至治疗时间(OTT)、患者年龄和入院时美国国立卫生研究院卒中量表(NIHSS)评分与五级mRS-90d评分之间的关联。采用广义线性模型(GLM)来预测每个患者组的mRS-90d评分。

结果

CVT患者拟合的GLM是年龄和NIHSS评分的函数。对于IVT、MT和IVT+MT患者,GLM还采用了OTT变量。将平均OTT缩短15分钟后,IVT使一名患者在mRS上实现有利的一步转变所需治疗人数(NNT)为30,MT为48,IVT+MT为21。

讨论与结论

本研究表明IVT、MT和IVT+MT的mRS-90d评分与OTT呈线性关联,并通过绝对效应量显示,缩短IVT和/或MT的OTT可为AIS患者带来显著的健康益处。即使是适度缩短OTT也会导致NNT大幅下降。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a8e/9386213/0445480ec86b/bmjno-2022-000312f06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a8e/9386213/0d224d22cc73/bmjno-2022-000312f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a8e/9386213/c9a9f9717e38/bmjno-2022-000312f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a8e/9386213/2798155354da/bmjno-2022-000312f03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a8e/9386213/83e834266000/bmjno-2022-000312f04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a8e/9386213/49aefdd75cdf/bmjno-2022-000312f05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a8e/9386213/0445480ec86b/bmjno-2022-000312f06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a8e/9386213/0d224d22cc73/bmjno-2022-000312f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a8e/9386213/c9a9f9717e38/bmjno-2022-000312f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a8e/9386213/2798155354da/bmjno-2022-000312f03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a8e/9386213/83e834266000/bmjno-2022-000312f04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a8e/9386213/49aefdd75cdf/bmjno-2022-000312f05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a8e/9386213/0445480ec86b/bmjno-2022-000312f06.jpg

相似文献

1
Prediction modelling the impact of onset to treatment time on the modified Rankin Scale score at 90 days for patients with acute ischaemic stroke.预测急性缺血性脑卒中患者发病至治疗时间对90天时改良Rankin量表评分的影响。
BMJ Neurol Open. 2022 Aug 16;4(2):e000312. doi: 10.1136/bmjno-2022-000312. eCollection 2022.
2
Optimising acute stroke care organisation: a simulation study to assess the potential to increase intravenous thrombolysis rates and patient gains.优化急性脑卒中护理组织:一项评估增加静脉溶栓率和患者获益潜力的模拟研究。
BMJ Open. 2020 Jan 20;10(1):e032780. doi: 10.1136/bmjopen-2019-032780.
3
Ischemic stroke and reperfusion therapies in diabetic patients.糖尿病患者的缺血性脑卒中与再灌注治疗。
Neurol Sci. 2022 Jul;43(7):4335-4348. doi: 10.1007/s10072-022-05935-x. Epub 2022 Feb 11.
4
Prognostic significance of age in patients with acute ischaemic stroke treated with intravenous thrombolysis.年龄对接受静脉溶栓治疗的急性缺血性脑卒中患者的预后意义。
Neurol Neurochir Pol. 2022;56(1):81-88. doi: 10.5603/PJNNS.a2022.0010. Epub 2022 Jan 21.
5
Clinical and Functional Outcomes of Patients Receiving Cerebral Reperfusion Therapy: A Stroke Databank Study in Brazil.接受脑再灌注治疗患者的临床和功能结局:巴西一项卒中数据库研究
Front Surg. 2022 Feb 25;9:799485. doi: 10.3389/fsurg.2022.799485. eCollection 2022.
6
Mechanical thrombectomy in patients with medical contraindications for intravenous thrombolysis: a prospective observational study.静脉溶栓存在医学禁忌证患者的机械取栓术:一项前瞻性观察研究。
J Neurointerv Surg. 2017 Nov;9(11):1041-1046. doi: 10.1136/neurintsurg-2016-012727. Epub 2016 Nov 7.
7
Endovascular therapy for acute ischaemic stroke: the Pragmatic Ischaemic Stroke Thrombectomy Evaluation (PISTE) randomised, controlled trial.急性缺血性卒中的血管内治疗:实用缺血性卒中血栓切除术评估(PISTE)随机对照试验。
J Neurol Neurosurg Psychiatry. 2017 Jan;88(1):38-44. doi: 10.1136/jnnp-2016-314117. Epub 2016 Oct 18.
8
Intravenous thrombolysis for acute ischemic stroke in Greece: the Safe Implementation of Thrombolysis in Stroke registry 15-year experience.希腊急性缺血性卒中的静脉溶栓治疗:卒中溶栓安全实施注册研究的15年经验
Ther Adv Neurol Disord. 2018 Jun 28;11:1756286418783578. doi: 10.1177/1756286418783578. eCollection 2018.
9
Mechanical thrombectomy versus systemic thrombolysis in MCA stroke: a distance to thrombus-based outcome analysis.大脑中动脉卒中的机械取栓术与全身溶栓治疗:基于血栓距离的结局分析
J Neurointerv Surg. 2016 Sep;8(9):878-82. doi: 10.1136/neurintsurg-2015-011964. Epub 2015 Sep 7.
10
Short and long-term outcomes after combined intravenous thrombolysis and mechanical thrombectomy versus direct mechanical thrombectomy: a prospective single-center study.静脉溶栓联合机械取栓与直接机械取栓后的短期和长期结局:一项前瞻性单中心研究。
J Thromb Thrombolysis. 2017 Aug;44(2):203-209. doi: 10.1007/s11239-017-1527-8.

引用本文的文献

1
Optimizing Prehospital Acute Transfer of Patients With Presumed Stroke Given Economic Constraints.在经济受限情况下优化疑似中风患者的院前急性转运
Eur J Neurol. 2025 Mar;32(3):e70112. doi: 10.1111/ene.70112.
2
Optimized density and locations of stroke centers for improved cost effectiveness of mechanical thrombectomy in patients with acute ischemic stroke.优化卒中专心的密度和位置,以提高急性缺血性脑卒中患者机械取栓的成本效益。
J Neurointerv Surg. 2024 Jan 12;16(2):156-162. doi: 10.1136/jnis-2023-020299.

本文引用的文献

1
Influence of time to endovascular stroke treatment on outcomes in the early versus extended window paradigms.血管内治疗时间对早期与扩展时间窗治疗模式结局的影响。
Int J Stroke. 2022 Mar;17(3):331-340. doi: 10.1177/17474930211006304. Epub 2021 Apr 7.
2
Mechanical thrombectomy with or without thrombolysis: A meta-analysis of RCTs.机械血栓切除术联合与不联合溶栓治疗:一项 RCT 的荟萃分析。
Acta Neurol Scand. 2021 May;143(5):554-557. doi: 10.1111/ane.13390. Epub 2021 Feb 1.
3
Endovascular Thrombectomy Versus Bridging Thrombolysis: Real-World Efficacy and Safety Analysis Based on a Nationwide Registry Study.
血管内血栓切除术与桥接溶栓治疗的比较:基于全国注册研究的真实世界疗效和安全性分析。
J Am Heart Assoc. 2021 Feb 2;10(3):e018003. doi: 10.1161/JAHA.120.018003. Epub 2021 Jan 26.
4
Pathway Design for Acute Stroke Care in the Era of Endovascular Thrombectomy: A Critical Overview of Optimization Efforts.血管内血栓切除术时代急性脑卒中护理的路径设计:优化努力的批判性综述。
Stroke. 2020 Nov;51(11):3452-3460. doi: 10.1161/STROKEAHA.120.030392. Epub 2020 Oct 19.
5
Mothership versus Drip-and-Ship Model for Mechanical Thrombectomy in Acute Stroke: A Systematic Review and Meta-Analysis for Clinical and Radiological Outcomes.急性卒中机械取栓的母舰式与点滴运送式模型对比:临床和影像学结局的系统评价与荟萃分析
J Stroke. 2020 Sep;22(3):317-323. doi: 10.5853/jos.2020.01767. Epub 2020 Sep 29.
6
Inter-hospital transfer for mechanical thrombectomy within the supraregional stroke network NEVAS.区域间卒中网络 NEVAS 内的机械取栓转院。
J Neurol. 2021 Feb;268(2):623-631. doi: 10.1007/s00415-020-10165-2. Epub 2020 Sep 5.
7
Implementation of a Prehospital Stroke Triage System Using Symptom Severity and Teleconsultation in the Stockholm Stroke Triage Study.应用症状严重程度和远程咨询实施院前卒中分诊系统:斯德哥尔摩卒中分诊研究。
JAMA Neurol. 2020 Jun 1;77(6):691-699. doi: 10.1001/jamaneurol.2020.0319.
8
Global, Regional and Country-Specific Burden of Ischaemic Stroke, Intracerebral Haemorrhage and Subarachnoid Haemorrhage: A Systematic Analysis of the Global Burden of Disease Study 2017.全球、区域和国家特定缺血性卒中、脑出血和蛛网膜下腔出血负担:2017 年全球疾病负担研究的系统分析。
Neuroepidemiology. 2020;54(2):171-179. doi: 10.1159/000506396. Epub 2020 Feb 20.
9
Endovascular Thrombectomy for Acute Ischemic Strokes: Current US Access Paradigms and Optimization Methodology.急性缺血性脑卒中的血管内血栓切除术:目前美国的介入途径与优化方法。
Stroke. 2020 Apr;51(4):1207-1217. doi: 10.1161/STROKEAHA.120.028850. Epub 2020 Feb 12.
10
Prehospital selection of thrombectomy candidates beyond large vessel occlusion: M-DIRECT scale.院前超急性大血管闭塞患者取栓治疗的选择:M-DIRECT 量表。
Neurology. 2020 Feb 25;94(8):e851-e860. doi: 10.1212/WNL.0000000000008998. Epub 2020 Jan 24.